Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats

被引:16
作者
Nishiyama, Tomoki [1 ]
机构
[1] Kamagaya Gen Hosp, Dept Anesthesiol & Crit Care, Chiba 2730121, Japan
关键词
Serotonin (5-HT)(2A) receptor; Endotoxin shock; Cytokine; Lung injury; TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; SEROTONIN; INTERLEUKIN-6; BINDING; SEPSIS; IDENTIFICATION; INVOLVEMENT; SUBTYPES; CELLS;
D O I
10.1016/j.ejphar.2009.03.041
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Serotonin (5-HT)(2A) receptors are involved in cytokine production in infection or sepsis. Therefore, 5-HT2A receptor antagonist might be useful to treat sepsis. The present study investigates the effects of a 5-HT2A receptor antagonist, sarpogrelate on endotoxin shock. Catheters were inserted into the femoral artery and vein of Sprague-Dawley rats. First, sarpogrelate 0 (control), 3, or 10 mg/kg dissolved in 0.5 ml of distilled water has been given, followed by endotoxin 10 mg/kg in saline 0.5 ml 5 min later. Blood pressure, pulse rate and survival rate were monitored in 20 rats per dose. Blood gas and plasma cytokine concentrations were measured in 8 rats per dose. In four rats each of sarpogrelate 0, 3, or 10 mg/kg, and sham operation, the lung histology was examined. Zero, 15, and 12 rats survived for 8 h in the control. 3 mg/kg, and 10 mg/kg groups, respectively. The control group had the lowest blood pressure, pulse rate, pH and arterial oxygen tension, and the highest arterial carbon dioxide tension and plasma IL-1 beta concentration. The increase of TNF-alpha was significantly lower in 3 mg/kg group than in the control group. Pathological changes of the lung were inhibited in 3 and 10 mg/kg groups. In conclusion, sarpogrelate might be effective to decrease production of pro-inflammatory cytokines, to keep hemodynamics, to inhibit lung damage, and to decrease mortality in endotoxin shock. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [41] Ergovaline acts as both an agonist and antagonist on serotonin receptor 5-HT2A in bovine ruminal and mesenteric vasculature
    Trotta, R.
    Harmon, D.
    Klotz, J.
    JOURNAL OF ANIMAL SCIENCE, 2018, 96 : 46 - 47
  • [42] Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat
    Monti, Jaime M.
    Jantos, Hector
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 553 (1-3) : 163 - 170
  • [43] AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats
    Kihara, H
    Hirose, K
    Koganei, H
    Sasaki, N
    Yamamoto, H
    Kimura, A
    Nishimori, T
    Shoji, M
    Yoshimoto, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) : 523 - 530
  • [44] Revised Pharmacophore Model for 5-HT2A Receptor Antagonists Derived from the Atypical Antipsychotic Agent Risperidone
    Shah, Urjita H.
    Gaitonde, Supriya A.
    Moreno, Jose L.
    Glennon, Richard A.
    Dukat, Malgorzata
    Gonzalez-Maeso, Javier
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (05): : 2318 - 2331
  • [45] (1R, 3S)-(-)-Trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity
    Booth, Raymond G.
    Fang, Lijuan
    Huang, Yingsu
    Wilczynski, Andrzej
    Sivendran, Sashikala
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 615 (1-3) : 1 - 9
  • [46] 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity:: interactions with global 5-HT depletion
    Winstanley, CA
    Theobald, DEH
    Dalley, JW
    Glennon, JC
    Robbins, TW
    PSYCHOPHARMACOLOGY, 2004, 176 (3-4) : 376 - 385
  • [47] 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion
    Catharine A. Winstanley
    David E. H. Theobald
    Jeffrey W. Dalley
    Jeffrey C. Glennon
    Trevor W. Robbins
    Psychopharmacology, 2004, 176 : 376 - 385
  • [48] Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease
    Ferguson, Marcus C.
    Nayyar, Tultul
    Ansah, Twum A.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 71 : 36 - 46
  • [49] Antithrombotic activity of AT-1015, a potent 5-HT2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time
    Kihara, H
    Koganei, H
    Hirose, K
    Yamamoto, H
    Yoshimoto, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 433 (2-3) : 157 - 162
  • [50] Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor
    Asano, Teita
    Tanaka, Ken-ichiro
    Tada, Arisa
    Shimamura, Hikaru
    Tanaka, Rikako
    Maruoka, Hiroki
    Mizushima, Tohru
    Takenaga, Mitsuko
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (19) : 3370 - 3381